BioNTech SE (BNTX) Enterprise Value (2018 - 2025)

BioNTech SE has disclosed Enterprise Value across 8 years of filings, most recently posting -$17.3 billion for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$17.3 billion, up 3.44% year-over-year; the trailing twelve-month figure through Dec 2025 was -$17.3 billion (up 3.44% YoY), and the FY2025 annual result was -$16.8 billion, up 6.28% from the prior year.
• Enterprise Value came in at -$17.3 billion for Q4 2025 at BioNTech SE, down from -$17.2 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.4 billion in Q3 2021 to a low of -$1459786.9 billion in Q1 2021.
• The 5-year median for Enterprise Value is -$16.2 billion (2023), against an average of -$73001.8 billion.
• Across the five-year window, Enterprise Value surged 100.0% in 2022 and plunged 690.51% in 2023, its largest moves.
• BioNTech SE's Enterprise Value stood at -$2.4 billion in 2021, then slumped by 504.7% to -$14.3 billion in 2022, then fell by 24.09% to -$17.8 billion in 2023, then decreased by 0.73% to -$17.9 billion in 2024, then gained by 3.44% to -$17.3 billion in 2025.
• The last three Enterprise Value figures came in at -$17.3 billion (Q4 2025), -$17.2 billion (Q3 2025), and -$15.8 billion (Q2 2025), per Business Quant data.